Saturday, June 20, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 106 of 1,261
  1. US 12036319

    Polyvalent sting activating compositions and uses thereof

    The Board of Regents of the University of Texas System · Granted Jul 16, 2024 · Expires Jul 11, 2044

    granted
  2. US 12037363

    Peptides for Covid-19 prevention and treatment

    SOTIRA COVID, LLC · Granted Jul 16, 2024 · Expires Jul 11, 2044

    granted
  3. US 12037388

    Anti-IL-33 antibodies and uses thereof

    REGENERON PHARMACEUTICALS, INC. · Granted Jul 16, 2024 · Expires Jul 11, 2044

    granted
  4. US 12037390

    Leptin antibodies and method of reducing leptin

    The Board of Regents of the University of Texas System · Granted Jul 16, 2024 · Expires Jul 11, 2044

    granted
  5. US 12036194

    Methods of administering solriamfetol to lactating women

    AXSOME MALTA LTD. · Granted Jul 16, 2024 · Expires Jul 11, 2044

    granted
  6. US 12036198

    Dosage forms and therapeutic uses of L-4-chlorokynurenine

    VISTAGEN THERAPUETICS, INC. · Granted Jul 16, 2024 · Expires Jul 11, 2044

    granted
  7. US 12038433

    Methods and apparatus for high-throughput screening for testing permeability and retention of compounds across biological barriers

    The Board of Regents of the University of Texas System · Granted Jul 16, 2024 · Expires Jul 11, 2044

    granted
  8. US 12037374

    Peptides, hydrogel compositions and methods of use thereof

    Regents of the University of Minnesota · Granted Jul 16, 2024 · Expires Jul 11, 2044

    granted
  9. US 12037411

    Antibodies, and bispecific antigen-binding molecules that bind HER2 and/or APLP2, conjugates, and uses thereof

    REGENERON PHARMACEUTICALS, INC. · Granted Jul 16, 2024 · Expires Jul 11, 2044

    granted
  10. US 12036269

    Human-enzyme mediated depletion of homocysteine for treating patients with hyperhomocysteinemia and homocystinuria

    The Board of Regents of the University of Texas System · Granted Jul 16, 2024 · Expires Jul 11, 2044

    granted
  11. US 12037616

    Methods and compositions for treating angiopoietin-like 3 (ANGPTL3) related conditions

    CRISPR THERAPEUTICS AG · Granted Jul 16, 2024 · Expires Jul 11, 2044

    granted
  12. US 12037607

    Methods of preparing hematopoietic progenitor cells in vitro

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jul 16, 2024 · Expires Jul 11, 2044

    granted
  13. US 12037410

    Methods and compositions for targeting Treg cells

    PRECISION BIOLOGICS, INC. · Granted Jul 16, 2024 · Expires Jul 11, 2044

    granted
  14. US 12036405

    System and method of electric-induced acoustic tomography for electrotherapy monitoring

    The Board of Regents of the University of Oklahoma · Granted Jul 16, 2024 · Expires Jul 11, 2044

    granted
  15. US 12035713

    Pest control using natural pest control agent blends

    TYRATECH, INC. · Granted Jul 16, 2024 · Expires Jul 11, 2044

    granted
  16. US 12036241

    Compositions and methods for immune cell modulation in adoptive immunotherapies

    Fate Therapeutics, Inc. · Granted Jul 16, 2024 · Expires Jul 11, 2044

    granted
  17. US 12036243

    BCMA CAR-T cells with enhanced activities

    Allogene Therapeutics, Inc. · Granted Jul 16, 2024 · Expires Jul 11, 2044

    granted
  18. US 12037401

    Anti-TrkB monoclonal antibodies and methods of use

    REGENERON PHARMACEUTICALS, INC. · Granted Jul 16, 2024 · Expires Jul 11, 2044

    granted
  19. WO 2024146923

    INHIBITEURS DE POLYMÉRISATION DE TUBULINE

    AB SCIENCE [FR] · Granted Jul 11, 2024 · Expires Jul 6, 2044

    granted
  20. US 12029735

    Polymorphic compounds and uses thereof

    Aldeyra Therapeutics, Inc. · Granted Jul 9, 2024 · Expires Jul 4, 2044

    granted
  21. US 12031132

    Systems and methods for the treatment of hemoglobinopathies

    Editas Medicine, Inc. · Granted Jul 9, 2024 · Expires Jul 4, 2044

    granted
  22. US 12031133

    GNAQ targeted dsRNA compositions and methods for inhibiting expression

    Alnylam Pharmaceuticals, Inc. · Granted Jul 9, 2024 · Expires Jul 4, 2044

    granted
  23. US 12031147

    Adeno-associated virus virions with variant capsids and methods of use thereof

    The Regents of the University of California · Granted Jul 9, 2024 · Expires Jul 4, 2044

    granted
  24. US 12029816

    Compositions and methods of making brittle-matrix particles through blister pack freezing

    The Board of Regents of the University of Texas System · Granted Jul 9, 2024 · Expires Jul 4, 2044

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.